Companies & Industry »Company News»Company News Details
Company News Details

BSE   14 Aug 18 | 12:00 AM

1166.85 22.85 (2%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532331
Face Value: N.A.

NSE   14 Aug 18 | 12:00 AM

1168.20 27.05 (2.37%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: AJANTPHARM
Performance
1 Week : Rs 1,185.30 (-1.56%)
1 Month : Rs 1,026.80 (13.64%)
1 Year : Rs 1,235.35 (-5.54%)
change companytradenow
Back

Ajanta Pharma launches acid reflux drug in US

Press Trust of India / New Delhi 18 Jul 16 | 04:22 PM

Ajanta Pharma has launched generic omeprazole and sodium bicarbonate capsules, used in the treatment of acid reflux and ulcers in the US market, after receiving final approval from the country's health regulator.

The company has launched the product in the US through its wholly-owned subsidiary, Ajanta Pharma USA Inc, Ajanta Pharma said in a filing to BSE.

Widgets Magazine

The approval from the United States Food and Drug Administration (USFDA) is for the capsules in the strengths of 20mg/1100 mg and 40 mg/1100 mg, it added.

The capsules are generic version of Santarus Inc's Zegerid capsules.

The company has 26 abbreviated new drug applications (ANDAs) of which it has received final approvals for 11, tentative nods for 1 ANDA, while 14 are under review with the USFDA, it added.

Shares of Ajanta Pharma were trading at Rs 1,620, up 1.37% in the afternoon trade on BSE.

Widgets Magazine

Sensex

Company Price Gain (%)
Sun Pharma.Inds.601.656.91
Yes Bank381.752.87
ICICI Bank332.302.17
Axis Bank618.302.15
Reliance Inds.1,210.952.00

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine